The 2nd Annual Pharmaceutical Microbiology East Coast conference is returning to the Battery Wharf Hotel, Boston, USA on April 10th and 11th, 2019
BOSTON, MA, UNITED STATES , November 30, 2018 /EINPresswire.com/ — The two-day conference will be discussing best practices and techniques to tackle microbial control challenges within the pharmaceutical microbiology industry.
The Chair for the event was recently announced to be James Drinkwater, Chairman at PHSS and Head of Aseptic Processing Technologies & GMP Compliance, Franz Ziel GmbH
James currently holds the position of Chairman for the Pharmaceutical and Healthcare Sciences Society (PHSS) and lead the PHSS Annex 1 focus group from which 100 pages of comments were provided to the EMA during the revision consultation process. Also as part of the UK delegation from UCL: University College London, to provide Jordanian and Saudi Arabia FDA inspectors training on Quality assurance sterile product manufacturing including environmental control and monitoring for aseptic processing, and he is aware of current challenges and knowledge gaps for both the industry in regulators.
Mr Drinkwater says “As conference chair for the 2nd Annual Pharmaceutical Microbiology East Coast event in Boston, it would be my pleasure to invite you to attend this meeting on April 10th and 11th 2019.
Pharmaceutical Microbiology is a constant within all areas of pharmaceutical manufacturing and the field has been undergoing a period of vast change. With advances in rapid microbial methods, changes to regulations, our increasing knowledge of the human microbiome and new testing methods, the implementation of new strategies for contamination control and applying quality risk management (QRM) are challenging us all.
The Pharmaceutical Microbiology East Coast Conference will include presentations from colleagues with expertise in the following emerging disciplines:
• Science and regulation: preparing suitable contamination control strategies and ensuring CGMP compliance. Including a keynote session on considered impact from revision on Annex 1 on a new Aseptic processing Filling line to provide an insight to attendees of preparation for this upcoming major revision in GMP requirements for future projects.
• Rapid microbial methods, both implementation and an industry perspective on process automation
• Quality control considerations in microbial therapies and mycoplasma testing
Please download the brochure from the website for the full list of speakers and 2-day programme.
The 2019 agenda for the event is packed with hot topics, such as revision of Annex 1, contamination control, regulations of endotoxin detection methods and control, environmental monitoring, rapid microbial methods, sterility assurance, mold isolation, risk mitigation for mycoplasma, animal sera and much more.
For the full agenda and speaker line-up, visit the website to download the brochure at:
Interested in sponsoring, exhibiting or speaking at this event?
Contact Alia Malick, Director, on +44 (0) 20 827 6168 or email email@example.com
For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or firstname.lastname@example.org
Pharmaceutical Microbiology East Coast
April, 10 & 11, 2019
Battery Wharf Hotel, Boston, USA
Follow us @SMiPharm
—- END —-
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
email us here
Source: EIN Presswire